Does tranexamic acid reduce risk of mortality on patients with hemoptysis?: A protocol for systematic review and meta-analysis

BACKGROUND: Although tranexamic acid (TXA), a readily accessible antifibrinolytic agent, is widely adopted in hemorrhage scenarios, its role on mortality in patients with hemoptysis remains uncertain. New evidence is yet to be generated to evaluate the risk of mortality after using TXA in patients w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Chen, Liang-Fu, Wang, Ting-Cheng, Lin, Ting-Yi, Pao, Po-Jia, Chu, Karen Chia-Wen, Yang, Chih-Hao, Chang, Jer-Hwa, Hsu, Chin-Wang, Bai, Chyi-Huey, Hsu, Yuan-Pin
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
3900
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137080/
https://ncbi.nlm.nih.gov/pubmed/34011056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025898
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars